Related Experiment Videos
Adverse effects of atypical antipsychotics
1Department of Psychiatry and Biobehavioral Science, University of California at Los Angeles School of Medicine, USA.
The Journal of Clinical Psychiatry
|October 5, 2001
Summary
Atypical antipsychotics may cause weight gain and metabolic issues like diabetes. Careful monitoring is essential when managing dementia symptoms with these drugs.
Area of Science:
- Pharmacology
- Geriatrics
- Endocrinology
Background:
- Atypical antipsychotics are frequently prescribed for behavioral and psychological symptoms of dementia (BPSD).
- These medications are associated with significant metabolic adverse effects.
- Metabolic derangements can exacerbate comorbidities in elderly patients.
Purpose of the Study:
- To highlight the metabolic risks associated with atypical antipsychotic use in dementia patients.
- To emphasize the importance of monitoring for weight gain, glucose, and lipid abnormalities.
- To inform clinical management strategies for BPSD.
Main Methods:
- Review of existing literature on atypical antipsychotics and metabolic side effects.
- Analysis of clinical guidelines for dementia management.
- Case study considerations (implied).
Main Results:
- Atypical antipsychotics are linked to increased risk of weight gain.
- Derangements in glucose metabolism (impaired glucose tolerance, new-onset diabetes) are a known side effect.
- Dyslipidemia is another common metabolic consequence.
Conclusions:
- The metabolic side effects of atypical antipsychotics necessitate proactive management in dementia care.
- Clinicians must weigh the benefits against the risks of these medications.
- Regular monitoring for weight, glucose, and lipid profiles is crucial for patient safety.